MARKET

KAPA

KAPA

KAIROS PHARMA LTD
AMEX
1.370
-0.010
-0.72%
Closed 19:59 02/10 EST
OPEN
1.380
PREV CLOSE
1.380
HIGH
1.440
LOW
1.350
VOLUME
124.34K
TURNOVER
0
52 WEEK HIGH
4.000
52 WEEK LOW
0.8510
MARKET CAP
17.59M
P/E (TTM)
-6.0088
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KAPA last week (0203-0207)?
Weekly Report · 1d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 5d ago
Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound’s Potential as a Therapeutic for Melanoma and Glioblastoma
Barchart · 5d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 02/04 12:05
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/04 10:12
Weekly Report: what happened at KAPA last week (0127-0131)?
Weekly Report · 02/03 12:44
More
About KAPA
Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Its products consist of five pre-clinical or clinical-trial stage drug candidates developed by it and designed to target immune response, and two therapeutic agents developed by its Enviro Therapeutics, Inc. (Enviro) subsidiary and designed to increase anti-tumor response in conjunction with cancer therapies by addressing resistance to these agents. Its product portfolio includes a variety of technologies licensed by its Enviro subsidiary and consists of compositions and methods for treating diseases and conditions by targeting CD105 and depleting mitochondrial DNA from the circulation. Its products include KROS 101, 102, 201, 301, 401, ENV 105 and 205.

Webull offers Kairos Pharma Ltd stock information, including AMEX: KAPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KAPA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KAPA stock methods without spending real money on the virtual paper trading platform.